Podcast Episode Details

Back to Podcast Episodes
Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis

Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis



Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.


Published on 4 weeks, 1 day ago






If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate